Exclusive

Publication

Byline

Location

Clinical Trial: Transformative Study of Orelabrutinib Combined with Pola-R-CHP Regimen in the First-Line Treatment of Patients with Intermediate-High Risk Diffuse Large B-Cell Lymphoma (DLBCL) (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Transformative Study of Orelabrutinib Combined with Pola-R-CHP Regimen in the First-Lin... Read More


Clinical Trial: Risk factors and predictive model for post-aneurysm subarachnoid hemorrhage shunt dependent hydrocephalus (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Risk factors and predictive model for post-aneurysm subarachnoid hemorrhage shunt depen... Read More


Clinical Trial: A multicenter, prospective, observational real-world study of Etrasimod in the treatment of Chinese adult patients with moderate to severe active ulcerative colitis (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, prospective, observational real-world study of Etrasimod in the treatmen... Read More


Clinical Trial: Modified double snare assisted EMR (mDS-EMR) VS ESD for rectal neuroendocrine tumors smaller than 1cm (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Modified double snare assisted EMR (mDS-EMR) VS ESD for rectal neuroendocrine tumors sm... Read More


Clinical Trial: A multicenter,phase Ⅲ,randomized open-label clinical study of BL-B01D1 versus chemotherapy physician-selected in recurrent/ metastatic nasopharyngeal carcinoma patients treated with PD-1/L1 monoclonal (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter,phase Ⅲ,randomized open-label clinical study of BL-B01D1 versus chemother... Read More


Clinical Trial: Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mutation status in non-small cell lung cancer and their response to targeted therapy. (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mut... Read More


Clinical Trial: A Study on the Correlation between Visual Quality after SMILE and LASEK Procedures and the Visual Conduction Pathways in Patients with Moderate to Low Myopia (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Correlation between Visual Quality after SMILE and LASEK Procedures and ... Read More


Clinical Trial: Efficacy and safety of targeted biological agents in the treatment of myasthenia gravis: A single-center retrospective study (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of targeted biological agents in the treatment of myasthenia gravis... Read More


Clinical Trial: Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Cor... Read More


Clinical Trial: Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Infusion Chemotherapy (HAIC) as Adjuvant Therapy After Radical Resection of Extrahepatic Biliary Tract Cancer (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Inf... Read More